RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $9,470,000 | -25.2% | 3,125,282 | -39.0% | 0.58% | -17.3% |
| Q3 2015 | $12,659,000 | -32.9% | 5,125,282 | -12.8% | 0.70% | -30.6% |
| Q2 2015 | $18,864,000 | -35.9% | 5,876,752 | -28.7% | 1.01% | -55.8% |
| Q1 2015 | $29,439,000 | -23.7% | 8,246,329 | -51.5% | 2.29% | +36.7% |
| Q4 2014 | $38,598,000 | +231.7% | 17,003,500 | +183.5% | 1.68% | +37.5% |
| Q3 2014 | $11,636,000 | -71.4% | 5,998,019 | -46.4% | 1.22% | -39.0% |
| Q2 2014 | $40,642,000 | +92.0% | 11,196,038 | +105.2% | 2.00% | -2.4% |
| Q1 2014 | $21,166,000 | +49.9% | 5,455,119 | +10.1% | 2.05% | +10.0% |
| Q4 2013 | $14,122,000 | +10.6% | 4,955,119 | +39.0% | 1.86% | -17.8% |
| Q3 2013 | $12,766,000 | +25.3% | 3,565,819 | +16.9% | 2.27% | +13.7% |
| Q2 2013 | $10,187,000 | – | 3,050,000 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |